The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Transitional Cell
  • Muscle, Smooth
  • Smoking
  • Urinary Bladder
  • Urinary Bladder Neoplasms

abstract

  • In this series, smoking characteristics were not found to be predictive of pathologic response after NC and RC, although this analysis was limited by the small study sample size. However, the harmful effects of smoking warrants continued emphasis on smoking cessation counseling in bladder cancer patients.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3905053

Digital Object Identifier (DOI)

  • 10.1007/s00345-013-1128-x

PubMed ID

  • 23842986

Additional Document Info

start page

  • 453

end page

  • 9

volume

  • 32

number

  • 2